Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 484M | 5.9B | 1.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 639M | 688M | 587M | 149M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 18M | 9M | 18M | 17M |
Other income expense | 509M | 493M | 461M | 22M |
Pretax income | 241M | 269M | 389M | 266M |
Tax provision | 46M | 43M | 101M | 52M |
Net income | 195M | 226M | 288M | 214M |
Basic EPS | 2.0 | — | 3 | 2.1 |
Diluted EPS | 2.0 | — | 3.0 | 2.1 |
Basic average shares | 93M | — | 94M | 97M |
Diluted average shares | 94M | — | 95M | 97M |
EBITDA | — | — | — | — |
Net income from continuing op. | 241M | 269M | 389M | 266M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |